Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Aurinia Pharmaceuticals Inc (AUP.TO)

Aurinia Pharmaceuticals Inc (AUP.TO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 2,147,902
  • Shares Outstanding, K 128,396
  • Annual Sales, $ 50,118 K
  • Annual Income, $ -102,680 K
  • 60-Month Beta 0.26
  • Price/Sales 32.26
  • Price/Cash Flow N/A
  • Price/Book 4.67
Trade AUP.TO with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -1.16
  • Most Recent Earnings -0.37 on N/A
  • Next Earnings Date 08/05/21
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
13.64 +22.87%
on 07/27/21
18.37 -8.76%
on 07/29/21
+0.69 (+4.29%)
since 06/30/21
3-Month
11.77 +42.40%
on 05/11/21
18.37 -8.76%
on 07/29/21
+0.44 (+2.70%)
since 04/30/21
52-Week
11.77 +42.40%
on 05/11/21
26.00 -35.54%
on 01/25/21
-1.21 (-6.73%)
since 07/30/20

Most Recent Stories

More News
U.S. Jobs Figures Due Ahead of Labour Day

Monday U.S. Economic Lookahead Pending home sales (July) Featured Earnings Zoom Video Communications ...

AUP.TO : 16.76 (-3.51%)
ZM : 272.88 (+0.19%)
CTLT : 136.39 (-3.50%)
STNE : 38.27 (-4.35%)
NTES : 83.99 (+3.26%)
PVH : 113.38 (+2.62%)
AMBA : 159.35 (-2.17%)
VEEV : 294.92 (-1.67%)
CHWY : 70.50 (+0.96%)
OKTA : 241.46 (-4.72%)
AVGO : 504.85 (-0.01%)
DOCU : 263.82 (-3.14%)
HRL : 40.94 (+0.34%)
Aurinia: Q2 Earnings Snapshot

VICTORIA, British Columbia (AP) _ Aurinia Pharmaceuticals Inc. (AUPH) on Thursday reported a loss of $47 million in its second quarter.

AUP.TO : 16.76 (-3.51%)
Stocks in play: Aurinia Pharmaceuticals Inc.

Will release its second-quarter 2021 financial results on Thursday, August 5, after the markets close. ...

AUP.TO : 16.76 (-3.51%)
Aurinia Pharmaceuticals to Release Second Quarter 2021 Financial Results on August 5, 2021

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) (the "Company") today announced that it will release its second quarter 2021 financial results on Thursday, August 5, 2021, after the markets close....

AUPH : 23.55 (+1.33%)
AUP.TO : 16.76 (-3.51%)
S&P Dow Jones Indices Announces Changes to the S&P/TSX Composite Index

COMTEX_390313364/2669/2021-07-23T17:15:30

AUPH : 23.55 (+1.33%)
AUP.TO : 16.76 (-3.51%)
SPGI : 445.33 (-1.71%)
Aurinia Pharmaceuticals Announces Delisting from the Toronto Stock Exchange

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) (Aurinia or the Company), a commercial stage biopharmaceutical company advancing therapies for severe autoimmune diseases, announced today it will...

AUPH : 23.55 (+1.33%)
AUP.TO : 16.76 (-3.51%)
Aurinia Announces Addition of Dr. Brinda Balakrishnan to the Board of Directors

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) (Aurinia or the Company) announced today the appointment of Dr. Brinda Balakrishnan, M.D., Ph.D., to the Company's Board of Directors effective June...

BMRN : 78.62 (+0.03%)
AUPH : 23.55 (+1.33%)
AUP.TO : 16.76 (-3.51%)
Aurinia Announces Results of the 2021 Annual General Meeting

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) ("Aurinia" or the "Company") is pleased to announce that the eight incumbent directors of the Company were elected at the Company's annual general...

AUPH : 23.55 (+1.33%)
AUP.TO : 16.76 (-3.51%)
Aurinia Announces Additional Analysis of its AURORA 1 Phase 3 Study Data Presented at ERA-EDTA 2021 Congress

--- The assessment follows the presentation of first interim results of AURORA 2 continuation study at EULAR 2021 -

AUPH : 23.55 (+1.33%)
AUP.TO : 16.76 (-3.51%)
Aurinia Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) (the "Company") today announced that members of the executive management team will participate in a fireside chat during the Jefferies Virtual Healthcare...

AUPH : 23.55 (+1.33%)
AUP.TO : 16.76 (-3.51%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar